Artículos de revistas sobre el tema "Ligase I Inhibitors"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "Ligase I Inhibitors".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
Alomari, Arqam, Robert Gowland, Callum Southwood, Jak Barrow, Zoe Bentley, Jashel Calvin-Nelson, Alice Kaminski et al. "Identification of Novel Inhibitors of Escherichia coli DNA Ligase (LigA)". Molecules 26, n.º 9 (25 de abril de 2021): 2508. http://dx.doi.org/10.3390/molecules26092508.
Texto completoCiarrocchi, Giovanni, Donald G. MacPhee, Les W. Deady y Leann Tilley. "Specific Inhibition of the Eubacterial DNA Ligase by Arylamino Compounds". Antimicrobial Agents and Chemotherapy 43, n.º 11 (1 de noviembre de 1999): 2766–72. http://dx.doi.org/10.1128/aac.43.11.2766.
Texto completoLama, Rati, Samuel L. Galster, Chao Xu, Luke W. Davison, Sherry R. Chemler y Xinjiang Wang. "Dual Targeting of MDM4 and FTH1 by MMRi71 for Induced Protein Degradation and p53-Independent Apoptosis in Leukemia Cells". Molecules 27, n.º 22 (8 de noviembre de 2022): 7665. http://dx.doi.org/10.3390/molecules27227665.
Texto completoShapiro, Adam B., Ann E. Eakin, Grant K. Walkup y Olga Rivin. "A High-Throughput Fluorescence Resonance Energy Transfer-Based Assay for DNA Ligase". Journal of Biomolecular Screening 16, n.º 5 (11 de marzo de 2011): 486–93. http://dx.doi.org/10.1177/1087057111398295.
Texto completoGorelik, Maryna, Stephen Orlicky, Maria A. Sartori, Xiaojing Tang, Edyta Marcon, Igor Kurinov, Jack F. Greenblatt et al. "Inhibition of SCF ubiquitin ligases by engineered ubiquitin variants that target the Cul1 binding site on the Skp1–F-box interface". Proceedings of the National Academy of Sciences 113, n.º 13 (14 de marzo de 2016): 3527–32. http://dx.doi.org/10.1073/pnas.1519389113.
Texto completoMarblestone, Jeffrey G., K. G. Suresh Kumar, Michael J. Eddins, Craig A. Leach, David E. Sterner, Michael R. Mattern y Benjamin Nicholson. "Novel Approach for Characterizing Ubiquitin E3 Ligase Function". Journal of Biomolecular Screening 15, n.º 10 (23 de septiembre de 2010): 1220–28. http://dx.doi.org/10.1177/1087057110380456.
Texto completoTobin, Lisa A., Aaron P. Rapoport, Ivana Gojo, Maria R. Baer, Alan E. Tomkinson y Feyruz V. Rassool. "DNA Ligase III Alpha and (Poly-ADP) Ribose Polymerase (PARP1) Are Therapeutic Targets in Imatinib-Resistant (IR) Chronic Myeloid Leukemia (CML)." Blood 114, n.º 22 (20 de noviembre de 2009): 853. http://dx.doi.org/10.1182/blood.v114.22.853.853.
Texto completoTAN, Ghee T., Sangkook LEE, Ik-Soo LEE, Jingwen CHEN, Pete LEITNER, Jeffrey M. BESTERMAN, Douglas A. KINGHORN y John M. PEZZUTO. "Natural-product inhibitors of human DNA ligase I". Biochemical Journal 314, n.º 3 (15 de marzo de 1996): 993–1000. http://dx.doi.org/10.1042/bj3140993.
Texto completoGoldenberg, Seth J., Jeffrey G. Marblestone, Michael R. Mattern y Benjamin Nicholson. "Strategies for the identification of ubiquitin ligase inhibitors". Biochemical Society Transactions 38, n.º 1 (19 de enero de 2010): 132–36. http://dx.doi.org/10.1042/bst0380132.
Texto completoMills, Scott D., Ann E. Eakin, Ed T. Buurman, Joseph V. Newman, Ning Gao, Hoan Huynh, Kenneth D. Johnson et al. "Novel Bacterial NAD+-Dependent DNA Ligase Inhibitors with Broad-Spectrum Activity and Antibacterial EfficacyIn Vivo". Antimicrobial Agents and Chemotherapy 55, n.º 3 (28 de diciembre de 2010): 1088–96. http://dx.doi.org/10.1128/aac.01181-10.
Texto completoHowes, Timothy R. L., Annahita Sallmyr, Rhys Brooks, George E. Greco, Darin E. Jones, Yoshihiro Matsumoto y Alan E. Tomkinson. "Structure-activity relationships among DNA ligase inhibitors: Characterization of a selective uncompetitive DNA ligase I inhibitor". DNA Repair 60 (diciembre de 2017): 29–39. http://dx.doi.org/10.1016/j.dnarep.2017.10.002.
Texto completoTomkinson, Alan E., Tasmin Naila y Seema Khattri Bhandari. "Altered DNA ligase activity in human disease". Mutagenesis 35, n.º 1 (20 de octubre de 2019): 51–60. http://dx.doi.org/10.1093/mutage/gez026.
Texto completoGiardina, Sarah F., Elena Valdambrini, Michael Peel, Manny D. Bacolod, Mace L. Rothenberg, Richard B. Lanman, J. David Warren y Francis Barany. "Cure-PROs: Next-generation targeted protein degraders." Journal of Clinical Oncology 41, n.º 16_suppl (1 de junio de 2023): e15101-e15101. http://dx.doi.org/10.1200/jco.2023.41.16_suppl.e15101.
Texto completoWatanabe, Bunta, Hiroaki Kirikae, Takao Koeduka, Yoshinori Takeuchi, Tomoki Asai, Yoshiyuki Naito, Hideya Tokuoka et al. "Synthesis and inhibitory activity of mechanism-based 4-coumaroyl-CoA ligase inhibitors". Bioorganic & Medicinal Chemistry 26, n.º 9 (mayo de 2018): 2466–74. http://dx.doi.org/10.1016/j.bmc.2018.04.006.
Texto completoBaum, Ellen Z., Steven M. Crespo-Carbone, Darren Abbanat, Barbara Foleno, Amy Maden, Raul Goldschmidt y Karen Bush. "Utility of Muropeptide Ligase for Identification of Inhibitors of the Cell Wall Biosynthesis Enzyme MurF". Antimicrobial Agents and Chemotherapy 50, n.º 1 (enero de 2006): 230–36. http://dx.doi.org/10.1128/aac.50.1.230-236.2006.
Texto completoKristan, Katja, Miha Kotnik, Marko Oblak y Uroš Urleb. "New High-Throughput Fluorimetric Assay for Discovering Inhibitors of UDP-N-Acetylmuramyl-l-Alanine: d-Glutamate (MurD) Ligase". Journal of Biomolecular Screening 14, n.º 4 (abril de 2009): 412–18. http://dx.doi.org/10.1177/1087057109332597.
Texto completoPavlides, Savvas C., Kuang-Tzu Huang, Dylan A. Reid, Lily Wu, Stephanie V. Blank, Khushbakhat Mittal, Lankai Guo et al. "Inhibitors of SCF-Skp2/Cks1 E3 Ligase Block Estrogen-Induced Growth Stimulation and Degradation of Nuclear p27kip1: Therapeutic Potential for Endometrial Cancer". Endocrinology 154, n.º 11 (1 de noviembre de 2013): 4030–45. http://dx.doi.org/10.1210/en.2013-1757.
Texto completoPowell, Jason A., Melissa R. Pitman, Julia R. Zebol, Paul A. B. Moretti, Heidi A. Neubauer, Lorena T. Davies, Alexander C. Lewis et al. "Kelch-like protein 5-mediated ubiquitination of lysine 183 promotes proteasomal degradation of sphingosine kinase 1". Biochemical Journal 476, n.º 21 (11 de noviembre de 2019): 3211–26. http://dx.doi.org/10.1042/bcj20190245.
Texto completoWan, Yichao, Chunxing Yan, Han Gao y Tingting Liu. "Small-molecule PROTACs: novel agents for cancer therapy". Future Medicinal Chemistry 12, n.º 10 (mayo de 2020): 915–38. http://dx.doi.org/10.4155/fmc-2019-0340.
Texto completoPandey, Monica, Sujeet Kumar, Gunaseelan Goldsmith, Mrinal Srivastava, Santhini Elango, Mohammad Shameem, Dibyendu Bannerjee, Bibha Choudhary, Subhas S. Karki y Sathees C. Raghavan. "Identification and characterization of novel ligase I inhibitors". Molecular Carcinogenesis 56, n.º 2 (27 de junio de 2016): 550–66. http://dx.doi.org/10.1002/mc.22516.
Texto completoWatt, Jessica E., Gregory R. Hughes, Samuel Walpole, Serena Monaco, G. Richard Stephenson, Philip C. Bulman Page, Andrew M. Hemmings, Jesus Angulo y Andrew Chantry. "Discovery of Small Molecule WWP2 Ubiquitin Ligase Inhibitors". Chemistry - A European Journal 24, n.º 67 (6 de noviembre de 2018): 17677–80. http://dx.doi.org/10.1002/chem.201804169.
Texto completoKuai, Jun, Yingzhi Bi, Yilin Qi, Deborah Conrady, Rajiv Govindaraj, Graham Hone, R. Aldrin Denny, Ken Carson, Geraldine Harriman y Fang Wang. "864 Identification of a novel allosteric oral Cbl-b inhibitor that augmented T cell response and enhanced NK cell killing in vitro and in vivo". Journal for ImmunoTherapy of Cancer 9, Suppl 2 (noviembre de 2021): A905. http://dx.doi.org/10.1136/jitc-2021-sitc2021.864.
Texto completoNicholson, B., Suresh Kumar, S. Agarwal, M. J. Eddins, J. G. Marblestone, J. Wu, M. P. Kodrasov, J. P. LaRocque, D. E. Sterner y M. R. Mattern. "Discovery of Therapeutic Deubiquitylase Effector Molecules". Journal of Biomolecular Screening 19, n.º 7 (14 de marzo de 2014): 989–99. http://dx.doi.org/10.1177/1087057114527312.
Texto completoBjij, Imane, Pritika Ramharack, Shama Khan, Driss Cherqaoui y Mahmoud Soliman. "Tracing Potential Covalent Inhibitors of an E3 Ubiquitin Ligase Through Target-Focused Modelling". Proceedings 22, n.º 1 (14 de noviembre de 2019): 103. http://dx.doi.org/10.3390/proceedings2019022103.
Texto completoGutierrez-Lugo, Maria-Teresa, Heather Baker, Joseph Shiloach, Helena Boshoff y Carole A. Bewley. "Dequalinium, a New Inhibitor of Mycobacterium tuberculosis Mycothiol Ligase Identified by High-Throughput Screening". Journal of Biomolecular Screening 14, n.º 6 (12 de junio de 2009): 643–52. http://dx.doi.org/10.1177/1087057109335743.
Texto completoChu, Yu-Yi, Mei-Kuang Chen, Yongkun Wei, Heng-Huan Lee, Weiya Xia, Ying-Nai Wang, Clinton Yam et al. "Targeting the ALK–CDK9-Tyr19 kinase cascade sensitizes ovarian and breast tumors to PARP inhibition via destabilization of the P-TEFb complex". Nature Cancer 3, n.º 10 (17 de octubre de 2022): 1211–27. http://dx.doi.org/10.1038/s43018-022-00438-2.
Texto completoLu, Jing, Yimin Qian, Kanak Raina, Martha Altieri, Hanqing Dong, Jing Wang, Xin Chen et al. "BRD4 Degradation By Protacs Represents a More Effective Therapeutic Strategy Than BRD4 Inhibitors in DLBCL". Blood 126, n.º 23 (3 de diciembre de 2015): 2050. http://dx.doi.org/10.1182/blood.v126.23.2050.2050.
Texto completoMartinez-Iglesias, Olaia, Alba Casas-Pais, Raquel Castosa, Andrea Díaz-Díaz, Daniel Roca-Lema, Ángel Concha, Álvaro Cortés, Federico Gago y Angélica Figueroa. "Hakin-1, a New Specific Small-Molecule Inhibitor for the E3 Ubiquitin-Ligase Hakai, Inhibits Carcinoma Growth and Progression". Cancers 12, n.º 5 (23 de mayo de 2020): 1340. http://dx.doi.org/10.3390/cancers12051340.
Texto completoChen, Qing, Weilin Xie, Deborah J. Kuhn, Peter M. Voorhees, Antonia Lopez-Girona, Derek Mendy, Laura G. Corral et al. "Targeting the p27 E3 ligase SCFSkp2 results in p27- and Skp2-mediated cell-cycle arrest and activation of autophagy". Blood 111, n.º 9 (1 de mayo de 2008): 4690–99. http://dx.doi.org/10.1182/blood-2007-09-112904.
Texto completoBjij, Imane, Pritika Ramharack, Shama Khan, Driss Cherqaoui y Mahmoud E. S. Soliman. "Tracing Potential Covalent Inhibitors of an E3 Ubiquitin Ligase through Target-Focused Modelling". Molecules 24, n.º 17 (28 de agosto de 2019): 3125. http://dx.doi.org/10.3390/molecules24173125.
Texto completoSallmyr, Annahita, Lisa Tobin, Alan E. Tomkinson y Feyruz V. Rassool. "Inhibiting Alternative Non Homologus Endjoining (NHEJ) Pathways: Therapeutic Targets in Chronic Myeloid Leukemia (CML)." Blood 112, n.º 11 (16 de noviembre de 2008): 1088. http://dx.doi.org/10.1182/blood.v112.11.1088.1088.
Texto completoLandré, Vivien, Barak Rotblat, Sonia Melino, Francesca Bernassola y Gerry Melino. "Screening for E3-Ubiquitin ligase inhibitors: challenges and opportunities". Oncotarget 5, n.º 18 (3 de septiembre de 2014): 7988–8013. http://dx.doi.org/10.18632/oncotarget.2431.
Texto completoParsons, William H., Arthur A. Patchett, Herbert G. Bull, William R. Schoen, David Taub, Jacqueline Davidson, Patricia L. Combs, James P. Springer y Hans Gadebusch. "Phosphinic acid inhibitors of D-alanyl-D-alanine ligase". Journal of Medicinal Chemistry 31, n.º 9 (septiembre de 1988): 1772–78. http://dx.doi.org/10.1021/jm00117a017.
Texto completovan der Meer, Laurens T., Jurgen A. F. Marteijn, Theo M. de Witte, Joop H. Jansen y Bert A. van der Reijden. "Gfi1 Protein Turnover Is Regulated by the Ubiquitin Ligase Triad1." Blood 108, n.º 11 (16 de noviembre de 2006): 1173. http://dx.doi.org/10.1182/blood.v108.11.1173.1173.
Texto completoTsukahara, Fujiko y Yoshiro Maru. "Bag1 directly routes immature BCR-ABL for proteasomal degradation". Blood 116, n.º 18 (4 de noviembre de 2010): 3582–92. http://dx.doi.org/10.1182/blood-2009-10-249623.
Texto completoWilson, Brice A. P., Donna Voeller, Emily A. Smith, Antony Wamiru, Ekaterina I. Goncharova, Gang Liu, Stanley Lipkowitz y Barry R. O’Keefe. "In Vitro Ubiquitination Platform Identifies Methyl Ellipticiniums as Ubiquitin Ligase Inhibitors". SLAS DISCOVERY: Advancing the Science of Drug Discovery 26, n.º 7 (21 de abril de 2021): 870–84. http://dx.doi.org/10.1177/24725552211000675.
Texto completoRana, Sandeep, Jayapal Reddy Mallareddy, Sarbjit Singh, Lidia Boghean y Amarnath Natarajan. "Inhibitors, PROTACs and Molecular Glues as Diverse Therapeutic Modalities to Target Cyclin-Dependent Kinase". Cancers 13, n.º 21 (2 de noviembre de 2021): 5506. http://dx.doi.org/10.3390/cancers13215506.
Texto completoCasaletto, Jessica B., Leta K. Nutt, Qiju Wu, Jonathan D. Moore, Laurence D. Etkin, Peter K. Jackson, Tim Hunt y Sally Kornbluth. "Inhibition of the anaphase-promoting complex by the Xnf7 ubiquitin ligase". Journal of Cell Biology 169, n.º 1 (11 de abril de 2005): 61–71. http://dx.doi.org/10.1083/jcb.200411056.
Texto completoMontecucco, A., M. Lestingi, G. Pedrali-Noy, S. Spadari y G. Ciarrocchi. "Use of ATP, dATP and their α-thio derivatives to study DNA ligase adenylation". Biochemical Journal 271, n.º 1 (1 de octubre de 1990): 265–68. http://dx.doi.org/10.1042/bj2710265.
Texto completoChen, Wei-Yi, Jui-Hsia Weng, Chen-Che Huang y Bon-chu Chung. "Histone Deacetylase Inhibitors Reduce Steroidogenesis through SCF-Mediated Ubiquitination and Degradation of Steroidogenic Factor 1 (NR5A1)". Molecular and Cellular Biology 27, n.º 20 (20 de agosto de 2007): 7284–90. http://dx.doi.org/10.1128/mcb.00476-07.
Texto completoTriola, Gemma, Stefan Wetzel, Bernhard Ellinger, Marcus A. Koch, Katja Hübel, Daniel Rauh y Herbert Waldmann. "ATP competitive inhibitors of d-alanine–d-alanine ligase based on protein kinase inhibitor scaffolds". Bioorganic & Medicinal Chemistry 17, n.º 3 (febrero de 2009): 1079–87. http://dx.doi.org/10.1016/j.bmc.2008.02.046.
Texto completoShrivastava, Nidhi, Jeetendra K. Nag, Jyoti Pandey, Rama Pati Tripathi, Priyanka Shah, Mohammad Imran Siddiqi y Shailja Misra-Bhattacharya. "Homology Modeling of NAD+-Dependent DNA Ligase of the Wolbachia Endosymbiont of Brugia malayi and Its Drug Target Potential Using Dispiro-Cycloalkanones". Antimicrobial Agents and Chemotherapy 59, n.º 7 (6 de abril de 2015): 3736–47. http://dx.doi.org/10.1128/aac.03449-14.
Texto completoAshraf, Zaman, Aamer Saeed y Humaira Nadeem. "Design, synthesis and docking studies of some novel isocoumarin analogues as antimicrobial agents". RSC Adv. 4, n.º 96 (2014): 53842–53. http://dx.doi.org/10.1039/c4ra07223e.
Texto completoKovač, Andreja, Vita Majce, Roman Lenaršič, Sergeja Bombek, Julieanne M. Bostock, Ian Chopra, Slovenko Polanc y Stanislav Gobec. "Diazenedicarboxamides as inhibitors of d-alanine-d-alanine ligase (Ddl)". Bioorganic & Medicinal Chemistry Letters 17, n.º 7 (abril de 2007): 2047–54. http://dx.doi.org/10.1016/j.bmcl.2007.01.015.
Texto completoDuckworth, Benjamin P., Todd W. Geders, Divya Tiwari, Helena I. Boshoff, Paul A. Sibbald, Clifton E. Barry, Dirk Schnappinger, Barry C. Finzel y Courtney C. Aldrich. "Bisubstrate Adenylation Inhibitors of Biotin Protein Ligase from Mycobacterium tuberculosis". Chemistry & Biology 18, n.º 11 (noviembre de 2011): 1432–41. http://dx.doi.org/10.1016/j.chembiol.2011.08.013.
Texto completoLee, Junglim, Deanne W. Sammond, Zeno Fiorini, Jonel P. Saludes, Michael G. Resch, Bing Hao, Wei Wang, Hang Yin y Xuedong Liu. "Computationally Designed Peptide Inhibitors of the Ubiquitin E3 Ligase SCFFbx4". ChemBioChem 14, n.º 4 (11 de febrero de 2013): 445–51. http://dx.doi.org/10.1002/cbic.201200777.
Texto completoBruning, John B., Ana C. Murillo, Ofelia Chacon, Raúl G. Barletta y James C. Sacchettini. "Structure of theMycobacterium tuberculosisd-Alanine:d-Alanine Ligase, a Target of the Antituberculosis Drug d-Cycloserine". Antimicrobial Agents and Chemotherapy 55, n.º 1 (18 de octubre de 2010): 291–301. http://dx.doi.org/10.1128/aac.00558-10.
Texto completoAndo, Kiyohiro, Yusuke Suenaga y Takehiko Kamijo. "DNA Ligase 4 Contributes to Cell Proliferation against DNA-PK Inhibition in MYCN-Amplified Neuroblastoma IMR32 Cells". International Journal of Molecular Sciences 24, n.º 10 (19 de mayo de 2023): 9012. http://dx.doi.org/10.3390/ijms24109012.
Texto completoSicari, Daria, Janine Weber, Elena Maspero y Simona Polo. "The NEDD4 ubiquitin E3 ligase: a snapshot view of its functional activity and regulation". Biochemical Society Transactions 50, n.º 1 (7 de febrero de 2022): 473–85. http://dx.doi.org/10.1042/bst20210731.
Texto completoRajalingam, Krishnaraj y Ivan Dikic. "Inhibitors of apoptosis catch ubiquitin". Biochemical Journal 417, n.º 1 (12 de diciembre de 2008): e1-e3. http://dx.doi.org/10.1042/bj20082215.
Texto completo